ALB and chronic kidney disease: The 2009/2010 extension of QOF did not specifically incentivise SCr testing or eGFR calculation, but incentivised the monitoring of urinary markers of kidney disease such as urinary albumin-creatinine ratio (ACR) in patients on the CKD register.9